NCT00463697View on ClinicalTrials.gov

A Study To Investigate The Effect Of Inhaling A Single Dose Of GW642444M In Asthmatic Patients

PHASE1CompletedINTERVENTIONAL

Enrollment

20

Participants

Timeline

Start Date

April 2, 2007

Primary Completion Date

August 4, 2007

Study Completion Date

August 4, 2007

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

DRUG

GW642444H (100mcg)

H salt

DRUG

placebo

placebo

DRUG

GW642444M (25, 100 & 400 mcg)

M salt

Trial Locations (3)

HA1 3UJ

GSK Investigational Site, Harrow

SE1 1YR

GSK Investigational Site, London

M23 9QZ

GSK Investigational Site, Manchester

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY